SCHEMBL9708300

SCHEMBL9708300

COC(=O)Cn1c(=O)[nH]c(=O)c2c1nc(C(C)C)n2Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 4/20 0.42
HPGD P15428 2/20 0.42
MAPT P10636 2/20 0.42
GAA P10253 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 3/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
PPARG P37231 2/20 0.40
TPH1 P17752 1/20 0.40
TPH2 Q8IWU9 1/20 0.40
AGTR1 P30556 1/20 0.39
AGTR2 P50052 1/20 0.39
PKM P14618 2/20 0.38
USP1 O94782 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9707246 0.90 MEN1 (0.46) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL9708112 0.89 KMT2A (0.42) MEN1KMT2ACYP2C9CYP2C19PPARG
SCHEMBL9707560 0.89 PPARG (0.42) KMT2APPARGAGTR1AGTR2USP1
SCHEMBL9707643 0.89 MEN1 (0.48) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL9707717 0.88 ALDH1A1 (0.49) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL9708525 0.88 TPH2 (0.47) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL9707557 0.88 ALDH1A1 (0.43) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL9707556 0.88 AGTR1 (0.40) MEN1KMT2AALDH1A1HPGDGAA
SCHEMBL9707464 0.87 MEN1 (0.45) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL9708371 0.87 KMT2A (0.44) MEN1KMT2ACYP2C9CYP2C19PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed